A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma
Clinical trial NCT02082977 · TERMINATED
Trial details
- NCT number
- NCT02082977
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-24
- Primary completion
- 2017-06-20
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.